文献速递糖尿病

全球糖尿病研究与照护挑战:EASD全球理事会评述

Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.
PubMed 文献 · Diabetologia · 2025-09-10

本文由EASD全球理事会撰写,评述全球糖尿病研究与照护面临的挑战,包括高收入国家与中低收入国家在资金、基础设施及临床试验代表性上的差距。文章建议发展全球研究网络、统一数据标准、改善药物可及性并建立国家糖尿病登记系统,呼吁采取统一的全球行动以缩小科研创新与临床实践之间的差距。

要点

  • 中低收入国家人群在临床试验中代表性不足,资金与基础设施存在差距。
  • 建议发展全球研究网络、统一数据标准并提升大数据分析可及性。
  • 呼吁改善胰岛素和新型疗法的可及性,并将新药纳入基本药物目录。

核心结论

  • EASD全球理事会呼吁采取统一的全球方法应对糖尿病研究与照护挑战,以缩小科学创新与临床实践之间的差距。

研究设计与样本

  • 本文为EASD全球理事会撰写的综述,讨论全球糖尿病研究与照护的挑战及建议。

主要发现

  • 高收入国家与中低收入国家在研究资金和基础设施方面存在差距。
  • 中低收入国家人群在临床试验中代表性不足,开展大规模研究项目面临挑战。
  • 人工智能整合涉及伦理和法律复杂性。
  • 基本药物尤其是胰岛素和新型疗法的可及性存在不平等,医疗基础设施存在差异。

关键数值与推荐

  • 建议发展全球研究网络,改进培训,标准化数据,并增强大数据分析的可及性。
  • 提议国际支持项目、改进医疗服务提供者培训,并将较新糖尿病药物纳入基本药物清单。
  • 强调全球筛查项目、通用糖尿病教育课程和标准化医疗检查清单的重要性。
  • 建议建立国家糖尿病登记系统,跨区域基准评估绩效,并加强国际合作。

临床怎么用

  • 糖尿病专家可作为照护协调者,通过结构化评估改善早期干预和长期结局。
  • 将新型糖尿病药物纳入基本药物清单以改善可及性。
  • 建立国家糖尿病登记系统并开展跨区域绩效基准评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This review article, developed by the EASD Global Council, addresses the growing global challenges in diabetes research and care, highlighting the rising prevalence of diabetes, the increasing complexity of its management and the need for a coordinated international response. With regard to research, disparities in funding and infrastructure between high-income countries and low- and middle-income countries (LMICs) are discussed. The under-representation of LMIC populations in clinical trials, challenges in conducting large-scale research projects, and the ethical and legal complexities of artificial intelligence integration are also considered as specific issues. The development of global research networks and strategies for improved training, standardisation of data and enhanced accessibility to big data analytics to drive innovation and personalised medicine are recommended. With regard to diabetes care, inequalities in access to essential medications, particularly insulin and novel therapies, and disparities in healthcare infrastructure are discussed. Proposed initiatives include international support programmes, improved healthcare provider training and the inclusion of newer diabetes medications in essential drug lists. The importance of global screening programmes, a universal diabetes education curriculum and standardised healthcare checklists is also emphasised. Regarding healthcare organisation, the development of national diabetes registers, benchmarking performance across regions and strengthening international collaborations are highly advised. The role of diabetes specialists as care coordinators and the need for structured assessments to improve early intervention and long-term outcomes are also discussed. Ultimately, the EASD Global Council urges action for a unified, global approach to diabetes research and care to bridge the gap between scientific innovation and clinical practice, ensuring equitable healthcare worldwide.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Giorgino F, Alzaid F, Pantea Stoian A, et al. Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. Diabetologia. 2025. PMID: 40928674. doi:10.1007/s00125-025-06504-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。